Biomet acknowledges much wider losses than initially reported; Sales reps can shape coronary stent choice during procedure;

@FierceMedDev: Device companies seek legal advice as Chinese corruption crackdown carries on. Item | Follow @FierceMedDev

@MarkHFierce: Medtronic is already rolling out its hospital solutions/consulting business. Diversification proceeds in earnest. Release | Follow @MarkHFierce

@MichaelGFierce: ICYMI: European public health group gets behind tighter device controls. Item | Follow @MichaelGFierce

> Biomet revised its fourth-quarter and fiscal year earnings to reflect much wider net losses than initially reported. Item

> Boston Scientific ($BSX), Medtronic ($MDT) and Abbott ($ABT) boosted their share of the Chinese coronary stent market to 33% in 2012. Domestic brands dipped to 65%, a 5% drop over the previous year, according to a new Reportlinker.com assessment. Item

> Medtronic says final, three-year results show its Symplicity renal denervation system produced major and sustained drops in blood pressure. Item

> The CEO of Encision, a surgical device/tool maker, died of an apparent heart attack on Aug. 31. Item

> San Diego's Tensys Medical won CE marks for two new iterations of the company's continuous, noninvasive hemodynamic patient monitoring systems. Item

> A congressionally required FDA report concludes that device companies seeking premarket approvals usually factor in the needs of women and other demographic subgroups in clinical studies supporting their applications. Blog

> Industry rep sales visits can influence the choice of a coronary stent during a catheterization procedure, a new study published in the American Heart Journal concludes. Story

> Researchers at the University of Western Australia developed a microscope in a needle that they say could transform breast cancer surgery through the use of special dyes to make tumor cells fluorescent and easier to find. Story

Biotech News

@FierceBiotech: ICYMI: Merck triggers patent war with Gilead over sofosbuvir rights. Story | Follow @FierceBiotech

@JohnCFierce: Schoenbaum's take on Amgen's demand for unblinded Kyprolis trial data: Poker move by Bradway to drop the price. | Follow @JohnCFierce

@RyanMFierce: ICYMI: Start-Up mag covered the trend of VC investments in clinical trials at major pharmas like Pfizer back in April. More | Follow @RyanMFierce

> U.K.'s Acacia banks $23.5M for PhIII drug to support cancer patients. Article

> PhII flop clouds future of Amgen, Cytokinetics heart failure drug. News

> Waksal brushes off jail time, plots biotech IPOs in a red-hot market. More

Pharma News

@FiercePharma: Executives' TV confessions in China are A) suspect, and B) a disturbing trend. More | Follow @FiercePharma

@EricPFierce: A court-appointed receiver is selling off equipment, patents from failed biosimilars plant. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Vivus CEO resigns after one month on the job; former J&J exec Seth H. Z. Fischer appointed. Release | Follow @CarlyHFierce

> GlaxoSmithKline's China unit officially engineered bribery, police say. News

> Novo Nordisk loses big U.S. contracts; Victoza, NovoLog sales to suffer. More

Pharma Manufacturing News

> Cubist recalls four lots of flagship antibiotic. More

> Quality issue keeps Apricus Biosciences from getting Swiss approval for Vitaros. Story

> Receiver selling off equipment, IP from failed biosimilars project. Article

> Hospira recalls product after hair found in one injector. News

> GSK gets interest from buyers for Romania plant. More

> India OKs Wockhardt plant banned by FDA. Report

Biotech Research News

@EmilyMFierce: Former cancer drug could treat diabetes, autoimmune diseases. More | Follow @EmilyMFierce

> Johnson & Johnson forges partnership to fight dengue fever. Article

> High blood pressure therapy speeds TB recovery. News

> Altered gene in mice extends lifespan by 20%. Report

> New opioid pain drug decreases tolerance, side effects. Story

> Worm genome reveals possible drug targets. Item

CRO News

> PPD snags Acurian for recruitment software. News

> CMO Lonza lopping off hundreds of jobs. More

> Duke's CRO nabs another trial deal. Story

> Psi expands in Italy amid global push. Report

> Report: Big CROs soared 10% last year. Article

Biotech IT News

> DNA software startup Desktop Genetics scores £375K in early funding. More

> Report: BGI readies for big genomics IPO. More

> Eagle Genomics captures £590,000 round to feed bioinformatics biz. Article

> AstraZeneca backs web portal for breast cancer docs. Story

> Quantia, provider of software to pharma, lands $10M B round. Item

> Eli Lilly, Humana partner on crunching diabetes data. Article

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.